Skip to main content
An official website of the United States government

Genitourinary Cancers Steering Committee Task Force Rosters

The Bladder, Prostate, and Renal task forces of the NCI Genitourinary Cancers Steering Committee were established to provide a forum for in-depth discussion of clinical trial concepts, provide advisory input on trial design, and make recommendations for clinical trial planning meetings.

Bladder Task Force

Co-Chairs

Andrea B. Apolo, M.D.
National Institutes of Health

Brian C. Baumann, M.D.
Springfield Memorial Hospital

Peter Black, M.D.
Vancouver Prostate Centre, University of British Columbia


Members

Stephanie Cooper Greenberg
Patient Advocate

Thomas W. Flaig, M.D.
University of Colorado, School of Medicine

Jonathan A. Gelfond, M.D., Ph.D.
University of Texas Health Science Center at San Antonio

Jessie R. Gills, M.D.
Louisiana State University

Noah Hahn, M.D.
Johns Hopkins University

Andrea L. Harzstark, M.D.
Kaiser Permanente

Ali Raza Khaki, M.D.
Stanford University School of Medicine

Girish Kulkarni, M.D.
University Health Network, Princess Margaret Cancer Centre

Matthew I. Milowsky, M.D.
University of North Carolina at Chapel Hill

Himanshu Nagar, M.D.
Memorial Sloan Kettering Cancer Center

Burton Needles, M.D.
Patient Advocate

Elizabeth R. Plimack, M.D., M.S.
Fox Chase Cancer Center

Melissa A. Reimers, M.D.
Washington University in Saint Louis

April A. N. Rose, M.D., Ph.D.
Jewish General Hospital

Sarmad Sadeghi, M.D., Ph.D., M.S.
University of Southern California, Keck School of Medicine

Srikala Sridhar, M.Sc., M.D., FRCPC
University Health Network, Princess Margaret Cancer Centre

Mark D. Tyson, II, M.D., M.P.H.
Mayo Clinic Arizona

Michael Woods, M.D.
Loyola University of Chicago

NCI CCCT Program Director

Abdul Tawab Amiri, Ph.D.
atawab@mail.nih.gov

 

Prostate Task Force

Co-Chairs

Ronald C. Chen, M.D., M.P.H.
University of Kansas Health System

Tanya B. Dorff, M.D.
City of Hope Medical Center

Todd Morgan, M.D.
University of Michigan Medicine


Members

Ana Aparicio, M.D.
University of Texas M.D. Anderson Cancer Center

Alan H. Bryce, M.D.
City of Hope Medical Center

Martin Chakoian
Patient Advocate

Yu-Hui Chen, M.S., M.P.H.
Dana-Farber Cancer Institute, Harvard University

Heather H. Cheng, M.D., Ph.D.
University of Washington

William Adrian Hall, M.D.
Medical College of Wisconsin

Karen Hoffman, M.D.
University of Texas M.D. Anderson Cancer Center

Thomas A. Hope, M.D.
University of California, San Francisco

Andrew Jonathan Huang, M.D.
Aspirus Cancer Care

David F. Jarrard, M.D.
University of Wisconsin, Madison, Carbone Cancer Center

Jun Luo, Ph.D.
Johns Hopkins University

Catherine Handy Marshall, M.D., M.P.H.
Johns Hopkins University

Rana R. McKay, M.D.
University of California San Diego

Helen H. Moon, M.D.
Southern California Permanente Medical Group

Charles H. Nash, III, M.D.
Northeast Georgia Health System

Michael Ong, M.D., FRCPC
University of Ottawa

Ganesh S. Palapattu, M.D.
University of Michigan Medicine

Frederic Pouliot, M.D., Ph.D., FRCSC
Laval University, CHU de Quebec

Srinivas Raman, M.D.
University Health Network, Princess Margaret Cancer Centre

Michael Schweizer, M.D.
University of Washington

Alexandra Sokolova, M.D.
Oregon Health & Science University

Kelly L. Stratton, M.D.
University of Oklahoma Health Sciences Center

Scott T. Tagawa, M.D., M.S.
Weill Cornell Medicine

Neha Vapiwala, M.D.
University of Pennsylvania

NCI CCCT Program Director

Abdul Tawab Amiri, Ph.D.
atawab@mail.nih.gov

 

Renal Task Force

Co-Chairs

Brian M. Shuch, M.D.
University of California Los Angeles

Tian Zhang, M.D., M.H.S.
University of Texas Southwestern


Members

Naveen Basappa, M.D.
University of Alberta

Mehmet Asim Bilen, M.D.
Emory University, Winship Cancer Institute

Gennady Bratslavsky, M.D.
SUNY Upstate Medical University

David Braun, M.D., Ph.D.
Yale University, School of Medicine

James Brugarolas, M.D., Ph.D.
University of Texas Southwestern

Brian A. Costello, M.D.
Mayo Clinic

Catherine Fahey, M.D., Ph.D.
University of North Carolina at Chapel Hill

Darren R. Feldman, M.D.
Memorial Sloan Kettering Cancer Center

Yasser M. Ged, M.B.B.S.
Johns Hopkins University

Jeffrey Graham, M.D., M.P.H.
University of Manitoba

Hans Hammers, M.D., Ph.D.
University of Texas Southwestern

Raquibul Hannan, M.D., Ph.D.
University of Texas Southwestern

Thai Huu Ho, M.D., Ph.D.
Medical University of South Carolina NCORP

Mariam Jafri, Ph.D., M.B.Ch.B.(Hons), M.Sc.
Queen's University

Bryan L. G. Lewis, J.D.
KidneyCAN

Rana R. McKay, M.D.
University of California San Diego

Sujata M. Patil, M.S., M.P.H., Ph.D.
Cleveland Clinic, Case Western Reserve University

Phillip M. Pierorazio, M.D.
University of Pennsylvania

Deepak Pruthi, M.D.
University of Texas Health Science Center at San Antonio

Sabina Signoretti, M.D.
Brigham and Women's Hospital, Harvard University

Eric A. Singer, M.D., M.A., M.S., FACS
Ohio State University Comprehensive Cancer Center

Chad Tang, M.D.
The University of Texas M.D. Anderson Cancer Center

Ulka Vaishampayan, M.D.
University of Michigan

Manish A. Vira, M.D.
Northwell Health

NCI CCCT Program Director

Abdul Tawab Amiri, Ph.D.
atawab@mail.nih.gov

 

  • Updated:
Email